An Exploratory Study to Explore the Correlation Between the Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response Using New Gonal-f Pen in Assisted Reproductive Technology (ART) Treatment in China
Phase of Trial: Phase IV
Latest Information Update: 30 May 2017
At a glance
- Drugs Follitropin alfa (Primary) ; Gonadotropin releasing hormone stimulants
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- Acronyms ARTIST
- Sponsors Merck KGaA
- 23 May 2017 Status changed from active, no longer recruiting to completed.
- 25 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 09 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.